We are live on ! Find out more
HA

HHLR Advisors Portfolio holdings

AUM $1.67B
1-Year Est. Return 7.53%
This Fund
S&P 500
This Quarter Est. Return
-1.51%
1 Year Est. Return
+7.53%
3 Year Est. Return
+82.23%
5 Year Est. Return
+55.28%
10 Year Est. Return
–
AUM
$4.67B
AUM Growth
-$124M
Cap. Flow
+$341M
Cap. Flow %
7.3%
Top 10 Hldgs %
73.2%
Holding
76
New
12
Increased
8
Reduced
8
Closed
12

Top Buys

Rank Stock Value
1
SE icon
Sea Limited
SE
+$248M
2
BABA icon
Alibaba
BABA
+$185M
3
DQ
Daqo New Energy
DQ
+$88.6M
4
PDD icon
Pinduoduo
PDD
+$65.6M
5
DASH icon
DoorDash
DASH
+$64.3M

Top Sells

Rank Stock Value
1
LEGN icon
Legend Biotech
LEGN
+$106M
2
IQ icon
iQIYI
IQ
+$93.5M
3
DIDI
DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share
DIDI
+$92.1M
4
ONON icon
On Holding
ONON
+$67.1M
5
LI icon
Li Auto
LI
+$64.4M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 40.38%
2 Healthcare 32.21%
3 Technology 16.3%
4 Consumer Staples 4%
5 Real Estate 3.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ONC
1
BeOne Medicines Ltd
ONC
$34B
$886M 18.98%
5,472,259
– –
JD icon
2
JD.com
JD
$43.3B
$545M 11.68%
8,485,071
+50,600
+0.6% +$2.92M
CRM icon
3
Salesforce
CRM
$151B
$384M 8.23%
2,326,337
+207,300
+10% +$36.6M
DASH icon
4
DoorDash
DASH
$86B
$301M 6.45%
4,691,023
+809,323
+21% +$64.3M
SE icon
5
Sea Limited
SE
$66.6B
$291M 6.24%
4,357,245
+2,903,945
+200% +$248M
VIPS icon
6
Vipshop
VIPS
$7.19B
$248M 5.32%
25,116,486
+2,965,993
+13% +$26.1M
LEGN icon
7
Legend Biotech
LEGN
$3.67B
$244M 5.23%
4,436,617
-2,500,000
-36% -$106M
BABA icon
8
Alibaba
BABA
$275B
$215M 4.61%
+1,891,000
New +$185M
BEKE icon
9
KE Holdings
BEKE
$17.7B
$166M 3.56%
9,250,689
+4,068,325
+79% +$57.3M
DQ
10
Daqo New Energy
DQ
$820M
$135M 2.89%
1,885,900
+1,785,900
+1,786% +$88.6M
MDLZ icon
11
Mondelez International
MDLZ
$83.9B
$116M 2.48%
1,862,164
– –
ONON icon
12
On Holding
ONON
$12.4B
$110M 2.35%
6,200,000
-3,100,000
-33% -$67.1M
CTKB icon
13
Cytek Biosciences
CTKB
$576M
$94M 2.01%
8,757,030
– –
PDD icon
14
Pinduoduo
PDD
$124B
$86.5M 1.85%
+1,399,928
New +$65.6M
NBP
15
NovaBridge Biosciences American Depositary Shares
NBP
$195M
$81.2M 1.74%
7,182,850
– –
JKS
16
JinkoSolar
JKS
$783M
$78.9M 1.69%
+1,140,416
New +$63.9M
IQ icon
17
iQIYI
IQ
$1.2B
$64.7M 1.39%
15,414,206
-23,234,271
-60% -$93.5M
YSG
18
Yatsen Holding
YSG
$314M
$62.7M 1.34%
8,090,343
– –
GOSS icon
19
Gossamer Bio
GOSS
$91M
$62.1M 1.33%
7,420,974
– –
ENFN
20
DELISTED
Enfusion, Inc.
ENFN
$50.8M 1.09%
4,975,183
– –
BBIO icon
21
BridgeBio Pharma
BBIO
$16.6B
$48.7M 1.04%
5,362,014
– –
PLTK icon
22
Playtika
PLTK
$1.54B
$43.4M 0.93%
3,280,699
– –
CPNG icon
23
Coupang
CPNG
$27.1B
$43M 0.92%
3,376,000
+25,600
+0.8% +$349K
YMM icon
24
Full Truck Alliance
YMM
$9.87B
$30.8M 0.66%
3,401,100
-6,189,842
-65% -$42.1M
KNSA icon
25
Kiniksa Pharmaceuticals
KNSA
$6.14B
$28.3M 0.61%
2,920,023
– –
1
2 3 4

Similar funds

TFS
Thoroughbred Financial Services Brentwood, Tennessee $1.67B AUM 37.77% 1-Year Est. Return
GC
Garde Capital Seattle, Washington $1.67B AUM 13.9% 1-Year Est. Return
PA
Proem Advisors Dallas, Texas $1.68B AUM 199.97% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.68B AUM 9.83% 1-Year Est. Return
JPM
JANA Partners Management New York $1.67B AUM 1.66% 1-Year Est. Return
NRI
NFP Retirement Inc Aliso Viejo, California $1.67B AUM 13.03% 1-Year Est. Return
CPO
Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return

HHLR Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, HHLR Advisors held 76 positions worth $4.67B, down 2.6% from $4.79B the previous quarter. Its ten largest holdings account for 73% of the portfolio.

HHLR Advisors deployed $341M of net new capital in Q2 2022, opening 12 new positions and adding to 8 existing holdings. Its largest new stake was Alibaba: 1,891,000 shares worth $215M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 40% of assets, up from 36% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Legend Biotech, an estimated $106M trimmed.

  • HHLR Advisors's largest Q2 2022 buy was Alibaba: 1,891,000 shares worth $215M.
  • HHLR Advisors added most to Sea Limited in Q2 2022, an estimated $248M increase.
  • HHLR Advisors's biggest Q2 2022 reduction was Legend Biotech, cutting an estimated $106M.
  • HHLR Advisors fully exited DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share in Q2 2022, selling an estimated $92.1M.
  • HHLR Advisors's ten largest holdings make up 73% of its $4.67B portfolio in Q2 2022.
  • HHLR Advisors opened 12 new positions and closed 12 in Q2 2022.
  • HHLR Advisors's portfolio value fell 2.6% quarter-over-quarter to $4.67B.

Based on HHLR Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.